azathioprine has been researched along with alprostadil in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (23.08) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Azzarone, A; Carrieri, G; Cillo, U; Fagiuoli, S; Francavilla, A; Gasbarrini, A; Scotti-Foglieni, C; Starzl, TE; Zeng, QH | 1 |
Chapman, JR; Hibbins, M | 1 |
Bowes, LG; Clunie, GJ; Dumble, LJ; Francis, DM; Hunter, S; Pollak, R; Ruwart, MJ | 1 |
Nagamatsu, T; Suzuki, Y | 1 |
Adolfs, MJ; Bonta, IL; Kort, WJ; Westbroek, DL | 1 |
Fisher, RA; Lee, HM; Posner, M; Shiffman, ML; Wolfe, L | 1 |
Allmayer, T; Auer, T; Iberer, F; Koshsorur, A; Petutschnigg, B; Rödl, S; Sabin, K; Tscheliessnigg, KH; Vujicic, R; Wasler, A | 1 |
1 trial(s) available for azathioprine and alprostadil
Article | Year |
---|---|
Effects of prostaglandin E1 therapy on cyclosporine A and creatinine levels after orthotopic heart transplantation.
Topics: Adolescent; Adult; Alprostadil; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Methylprednisolone; Middle Aged; Tissue Donors | 1994 |
12 other study(ies) available for azathioprine and alprostadil
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1.
Topics: Alprostadil; Animals; Azathioprine; Cell Division; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hepatectomy; Immunosuppressive Agents; Liver; Liver Regeneration; Male; Methylprednisolone; Mycophenolic Acid; Rats; Rats, Inbred F344; Ribonucleosides | 1992 |
In vitro assessment of triple-therapy immunosuppression and prostaglandin analogues enisoprost and misoprostol.
Topics: Alprostadil; Azathioprine; Cells, Cultured; Cyclosporine; Drug Interactions; Drug Synergism; Female; Humans; Immunosuppressive Agents; Lymphocytes; Male; Methylprednisolone; Misoprostol; Reference Values; Regression Analysis; Uremia | 1992 |
Prostaglandin E1 and E2 suppression of in vitro lymphoid responses to alloantigen.
Topics: Alprostadil; Azathioprine; Cyclosporins; Dinoprostone; Humans; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Methylprednisolone; Receptors, Interleukin-2 | 1989 |
Antinephritic effect of prostaglandin E1 on serum sickness nephritis in rats. (3). Suppression of leukocytes by prostaglandin E1 as a mechanism for preventing immune complex glomerulonephritis.
Topics: Alprostadil; Animals; Antigen-Antibody Complex; Azathioprine; Glomerulonephritis; Leukocyte Count; Leukocytes; Male; Proteinuria; Rats; Rats, Inbred Strains; Serum Sickness | 1986 |
Synergism of (15 S)-15-methyl-prostaglandin E1 with either azathioprine or prednisolone on the survival of heart allografts in rats.
Topics: Alprostadil; Animals; Azathioprine; Drug Synergism; Graft Survival; Heart Transplantation; Male; Prednisolone; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains; Time Factors | 1982 |
Induction with OKT3 and prostaglandin E1 in liver transplantation.
Topics: Adult; Aged; Alprostadil; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Infections; Infusions, Intravenous; Liver Transplantation; Lymphocyte Count; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prospective Studies; Reoperation; Survival Rate | 1994 |